Silvercrest Asset Management’s Altimmune ALT Stock Holding History

Silvercrest Asset Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$315K	Hold	103,500	–	–	﹤0.01%	757
2026 Q1	$319K	Hold	103,500	–	–	﹤0.01%	759
2025 Q4	$374K	Hold	103,500	–	–	﹤0.01%	758
2025 Q3	$390K	Hold	103,500	–	–	﹤0.01%	725
2025 Q2	$401K	Hold	103,500	–	–	﹤0.01%	737
2025 Q1	$518K	Hold	103,500	–	–	﹤0.01%	695
2024 Q4	$746K	Hold	103,500	–	–	0.01%	634
2024 Q3	$635K	Hold	103,500	–	–	﹤0.01%	623
2024 Q2	$688K	Hold	103,500	–	–	﹤0.01%	669
2024 Q1	$1.05M	Hold	103,500	–	–	0.01%	604
2023 Q4	$1.16M	Hold	103,500	–	–	0.01%	564
2023 Q3	$269K	Hold	103,500	–	–	﹤0.01%	763
2023 Q2	$365K	Hold	103,500	–	–	﹤0.01%	719
2023 Q1	$437K	Buy	103,500 +41,000	+66%	+$487K	﹤0.01%	670
2022 Q4	$1.03M	Hold	62,500	–	–	0.01%	575
2022 Q3	$798K	Hold	62,500	–	–	0.01%	585
2022 Q2	$731K	Hold	62,500	–	–	0.01%	603
2022 Q1	$381K	Buy	+62,500	New	+$460K	﹤0.01%	727

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Silvercrest Asset Management's ALT Position: Q2 2026 in Review

Silvercrest Asset Management held its Altimmune (ALT) position steady in Q2 2026 at 103,500 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #757.

Silvercrest Asset Management first reported a position in ALT in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.16M in Q4 2023. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

Silvercrest Asset Management held 103,500 shares of Altimmune worth $315K as of Q2 2026.
Silvercrest Asset Management left its Altimmune share count unchanged in Q2 2026.
Altimmune made up ﹤0.01% of Silvercrest Asset Management's portfolio in Q2 2026, its #757 holding.
Silvercrest Asset Management first reported a position in Altimmune in Q1 2022 and has held it in 18 quarters since.
Silvercrest Asset Management's Altimmune position peaked at $1.16M in Q4 2023.
211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.